Advanced eClinical Training (ACT), a national healthcare workforce training provider, today announced the continued expansion of its nationwide clinical partner network, now spanning more than 1,000 ...

Labcorp Venture Fund, Mayo Clinic, Sutter Health, InterVest, MGFO, PGGM, Puma Venture Capital, and ROM Utrecht invest alongside existing investors Invest-NL, EIC Fund, Fred Moll, NYBC Ventures, and ...

Orally administered sucrose reduced pain scores during and shortly after venipuncture among neonates compared with standard care.

Takeda Pharmaceutical Company Limited (NYSE:TAK) is one of the most promising stocks under $20. On March 2, Takeda and ...

HealthDay News — For preterm and term neonates, sucrose appears to reduce pain scores during or shortly after venipuncture compared with no intervention, water, or standard care, according to research ...

Vitestro's ARPD blood-drawing robot gained an EU CE mark in 2024 and launched in the healthcare settings across the region in March 2025.

Vitestro secures $70M Series B funding to expand its autonomous robotic blood collection technology and global healthcare adoption.

The company is scaling up manufacturing and commercial activities as it prepares to enter the U.S. market via the Food and Drug Administration’s de novo pathway.

CancerGuard is a multi-cancer early detection blood test from Exact Sciences that runs through a clinician-ordered lab workflow and can trigger follow-up ...

ACT expands its network of 1,000+ healthcare partners nationwide - extern-to-hire workforce pathways for medical ...